• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Furiex Pharmaceuticals Inc

+ Add to Watchlist


76.7200 USD 1.9900 2.53%

As of 14:16:01 ET on 04/16/2014.

Snapshot for Furiex Pharmaceuticals Inc (FURX)

Open: 79.2300 Day's Range: 76.0200 - 79.7200 Volume: 142,283
Previous Close: 78.7100 52wk Range: 32.0100 - 121.9700 1-Yr Rtn: +125.91%

Stock Chart for FURX

No chart data available.
  • FURX:US 76.7200
  • 1D
  • 1M
  • 1Y
Interactive FURX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FURX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.9800
Est. EPS (USD) (12/2014) -2.0050
Est. PEG Ratio -
Market Cap (M USD) 832.12
Shares Outstanding (M) 10.81
30 Day Average Volume 230,305
Price/Book (mrq) 43.5645
Price/Sale (ttm) 10.9379
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FURX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FURX

Furiex Pharmaceuticals Inc. is a drug development company. The company partners with pharmaceutical and biotechnology companies and has a diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and a product on the market. Furiex serves customers in North Carolina.

June S AlmenoffPresident/Chief Medical OfcrSailash PatelCFO/VP:Strategic Development
Paul S CovingtonSenior VP:Clinical Dev & OpsGail F McIntyreSenior VP:Research
More Company Profile & Key Executives for FURX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil